Suchergebnisse - "Diehl, Volker"

PubPharm (509)

1

Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma

enthalten in: Leukemia | 2024

von Fuchs, M. | Jacob, A. | Kaul, H. | +26

2

Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma

enthalten in: British journal of haematology | 2022

von Kreissl, S. | Voltin, C. | Kaul, H. | +10

3

Impact of bone marrow involvement on early positron emission tomography response and progression‐free survival in the HD18 trial for patients with advanced‐stage Hodgkin lymphoma

enthalten in: British Journal of Haematology | 2022

von Kreissl, S. | Voltin, C. | Kaul, H. | +10

4

PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18) : follow-up analysis of an international, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2021

von Kreissl, S. | Goergen, H. | Buehnen, I. | +32

5

Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma : a report from the German Hodgkin Study Group

enthalten in: British journal of haematology | 2021

von Eichenauer, D. | Müller, H. | Elger, L. | +8

6

Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma : long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

enthalten in: The Lancet. Haematology | 2021

von Gillessen, S. | Plütschow, A. | Fuchs, M. | +11

CommentIn: Lancet Haematol. 2021 Apr;8(4):e243-e245. - PMID 33770475

7

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Borchmann, P. | Plütschow, A. | Kobe, C. | +33

CommentIn: Lancet Oncol. 2021 Feb;22(2):161-162. - PMID 33539737

8

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial

enthalten in: The lancet / Oncology | 1 February 2021

von Borchmann, P. | Plütschow, A. | Kobe, C. | +33

9

Non‐Hodgkin lymphoma after treatment for classical Hodgkin lymphoma : a report from the German Hodgkin Study Group

enthalten in: British Journal of Haematology | 2021

von Eichenauer, D. | Müller, H. | Elger, L. | +8

10

Health-Related Quality of Life in Patients With Hodgkin Lymphoma : A Longitudinal Analysis of the German Hodgkin Study Group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Kreissl, S. | Müller, H. | Goergen, H. | +15

CommentIn: J Clin Oncol. 2020 Sep 1;38(25):2821-2823. - PMID 32650684

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[51]